Darbepoetin in chronic kidney disease and dialysis patients; an updated review of outcomes
Individuals with chronic renal failure in stage three and after demonstrate anemia as a frequent complication. Although target hemoglobin levels remain debatable in pre-dialysis and dialysis patients, correction of anemia with erythropoiesis-stimulating agents (ESAs) has resulted in reduced need for...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Society of Diabetic Nephropathy Prevention
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d275bea20fd24c25bdd81d04447f67e9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!